Press releases

Press releases
Title
BIOASTER Awarded Grant to Develop Multiplex Rapid Diagnostics for Neglected Tropical Diseases Plaguing Millions Globally
Press release : BIOASTER & ADOR Diagnostics Collaborate in the Field of Molecular Diagnostics in Infectious Diseases
Lancement du projet NextGenBioProcess, lauréat de l’appel à projet R&D Booster
BIOASTER exclusively licenses blood-based biomarkers for defining immune status of critically ill patients in intensive care units.
Pherecydes Pharma and BIOASTER join forces in the treatment of bacteremia
BIOASTER Awarded Grant for the Development of a New Multiplex Technology Adapted to Point of Care Diagnosis
BIOASTER collaborates with Evotec to develop a rapid diagnostic test
New collaboration with PiLeJe laboratoire
Xavier Morge is appointed CEO of BIOASTER
We formalize strategic collaboration to conduct Next Generation Sequencing technology evaluation in microbiology
FIND and BIOASTER collaborate on clinical research
EVOTEC & BIOASTER partner to build a technology and innovation hub in Lyon
New collaboration Gustave Roussy – IRT BIOASTER
Mologic and Institut Pasteur de Dakar launch accelerated programme to develop rapid diagnostic test for Ebola
Launch of EU Research Project ImmunoSep: Advancing Personalised Immunotherapy in Sepsis
Enterome collaborates with BIOASTER Institute to provide new insights into mechanisms of potential microbiome-derived cancer immunotherapies
BIOASTER Awarded Grant for the Development of Rapid Diagnostics for Neglected Tropical Diseases
BioFilm Pharma and BIOASTER collaborate to accelerate the emergence of a new class of drugs to fight antibiotic resistance and chronic infections
A new collaboration with Kaleido & MetaGenoPolis to investigate the health potential of a novel class of therapies targeting the microbiome
BIOASTER obtains certification to be recognized as a non profit organization in the USA